Intravenous heparin initiates in-vivo synthesis and release of thromboxane in angina pectoris.
D000787:Angina Pectoris / Q000097:blood*; D000788:Angina Pectoris, Variant / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D013929:Thromboxane B2 / Q000096:biosynthesis / Q000097:blood* / Q000378:metabolism; D013931:Thromboxanes / Q000097:blood*
D005230:Fatty Acids, Nonesterified; D013931:Thromboxanes; D013929:Thromboxane B2; D006493:Heparin